COMMUNIQUÉS West-GlobeNewswire

Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
25/02/2026
REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today reported [...]
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
25/02/2026
BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
25/02/2026
Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company [...]
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
25/02/2026
Enrollment completed in both Phase 3 chronic spontaneous urticaria global registration studies (EMBARQ-CSU 1 and 2) six months ahead of guidance; Topline data expected in Q4 26; BLA submission planned for 2027 Phase 3 [...]
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
25/02/2026
LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the TD Cowen 46 th Annual Health Care Conference [...]
Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
25/02/2026
Q4 2025 net product revenue for ZORYVE ® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025 Full year 2025 net product revenue for ZORYVE was $372.1 million, an [...]
Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1
25/02/2026
In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete lesion healing compared with 20% receiving investigator’s choice therapy (ICT [...]
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
25/02/2026
DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9 th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of [...]
Curaechoice and Fast Pace Health Partner to Expand Affordable Healthcare Access Across Multiple States
25/02/2026
Curaechoice members now have enhanced access to covered services at over 300 Fast Pace Health clinics at $0 cost Birmingham, ALABAMA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Curaechoice, the nation’s #1 leader in No-Cost [...]
The Integrated Healthcare Association Recognizes California Provider Organizations for Medicare Advantage Performance
25/02/2026
IHA’s Align. Measure. Perform. Medicare Advantage program celebrates top-performing and most-improved providers. OAKLAND, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) today [...]
IBA – TRANSPARENCY NOTIFICATION
25/02/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 25, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
IBA SA – NOTIFICATION TRANSPARENCE
25/02/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 25 février 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
25/02/2026
The SPARK NS Translational Research Program now includes 22 projects that are collectively eligible for up to $44 million in funding and support for drug development MENLO PARK, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE [...]
RAMSAY SANTE : Half-year results at the end of December 2025
25/02/2026
PRESS RELEASE Paris, 25 th February 2026 Half-year results at the end of December 2025 Quality offering driving revenue growth, with continued efficiency supporting operational profitability Public funding to mitigate [...]
RAMSAY SANTE : résultats semestriels à fin décembre 2025
25/02/2026
COMMUNIQUÉ DE PRESSE Paris, le 25 février 2026 Résultats semestriels à fin décembre 2025 Une croissance portée par une offre de qualité et une rentabilité opérationnelle soutenue par des gains de productivité Des [...]
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
25/02/2026
MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative cell therapy for life-threatening rare pediatric and chronic aging-related [...]
Genmab to Participate in Upcoming Investor Conferences
25/02/2026
Media Release COPENHAGEN, Denmark; February 25, 2026 Genmab A/S (Nasdaq: GMAB ) announced today that members of its E xecutive Committee will participat e in fireside chats at the following investor conferences in March [...]
The Developing Doctor Releases New Book on Managing High-Functioning Anxiety
25/02/2026
"How To Relax Without Losing Your Edge" by Dr. Ben Reinking Offers a Modern Guide for Ambitious Professionals Iowa City, IOWA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- IOWA CITY, IA — High-functioning anxiety is often masked [...]
Baba Emerges from Stealth with Over $6.5 Million in Seed Funding to Expand Medicare-Covered Patient Advocacy for Older Adults
25/02/2026
Public debut includes Medicare- and Medicare Advantage-covered advocacy model and forthcoming Johns Hopkins clinical study NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Baba , a Medicare- and Medicare Advantage-covered [...]

Pages